FDA Clears Roche and C2N Alzheimer’s Blood Tests, Expanding Earlier Amyloid Detection
Health

FDA Clears Roche and C2N Alzheimer’s Blood Tests, Expanding Earlier Amyloid Detection

The FDA cleared Roche’s Elecsys pTau217 and C2N Diagnostics’ PrecivityAD2, including the first Alzheimer’s blood test in...

Noa Feldman 👁 28 💬 0
Siemens Healthineers Cuts Revenue Outlook on Diagnostics Weakness, But Tariff Refunds Lift Profit
Companies

Siemens Healthineers Cuts Revenue Outlook on Diagnostics Weakness, But Tariff Refunds Lift Profit

The German medical equipment giant lowered its full-year revenue growth forecast to 3.5–4% as its diagnostics unit drags...

Declan Byrne 👁 48 💬 0